Alera Investment Advisors’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,288
Closed -$387K 178
2022
Q4
$387K Sell
2,288
-15
-0.7% -$2.72K 0.09% 127
2022
Q3
$431K Buy
2,303
+41
+2% +$8.65K 0.12% 111
2022
Q2
$368K Buy
2,262
+1
+0% +$158 0.1% 130
2022
Q1
$425K Buy
+2,261
New +$430K 0.1% 128

Other funds holding RGEN

Alera Investment Advisors's RGEN Position: Q1 2023 in Review

Alera Investment Advisors sold out of Repligen (RGEN) in Q1 2023, closing a stake of 2,288 shares — an estimated $387K sold.

Alera Investment Advisors first reported a position in RGEN in Q1 2022 and held it in 4 quarters. The position peaked at $431K in Q3 2022. 446 funds tracked by Wall St. Rank hold RGEN as of Q1 2023.

  • Alera Investment Advisors reported no remaining Repligen position as of Q1 2023 after selling out during the quarter.
  • Alera Investment Advisors sold 2,288 Repligen shares in Q1 2023, an estimated $387K.
  • Alera Investment Advisors first reported a position in Repligen in Q1 2022 and held it in 4 quarters.
  • Alera Investment Advisors's Repligen position peaked at $431K in Q3 2022.
  • 446 funds tracked by Wall St. Rank held Repligen as of Q1 2023.

Based on Alera Investment Advisors's 13F filing for Q1 2023, filed 2 May 2023.